Literature DB >> 11465837

Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children.

Y J Yang1, J C Yang, Y M Jeng, M H Chang, Y H Ni.   

Abstract

BACKGROUND: Little is known about the prevalence of antibiotic-resistant Helicobacter pylori infection in children. Culture and antimicrobial susceptibility testing are generally time-consuming and not a routine in many hospitals.
OBJECTIVE: To investigate the prevalence of clarithromycin-resistant H. pylori strains in children, to identify those isolates via rapid methodology and to examine the severity of gastritis caused by the antibiotic-resistant H. pylori isolates.
METHODS: Enrolled were 245 children investigated for H. pylori infection by endoscopic examination. The gastric antral specimens were subjected to DNA extraction and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) with primers specific to the H. pylori 23S rRNA gene. Conventional bacterial cultures were performed simultaneously as the diagnostic standard. Minimal inhibitory concentrations of clarithromycin and metronidazole were determined by E test. This was used as a standard to determine the sensitivity and specificity of the above PCR-RFLP assay. The specimens were processed for histologic examination and evaluated by the updated Sydney system.
RESULTS: H. pylori was isolated in 67 of the 245 children; 12 (18%) of them were clarithromycin-resistant and 6 (9%) were metronidazole-resistant. No difference in histologic examinations was noted between the antibiotic-resistant and -susceptible strains. We performed PCR-RFLP with all 12 clarithromycin-resistant isolates: 10 had a 23S ribosomal RNA A2144G point mutation; 1 had a mixture of an A2143G point mutant and susceptible strains; and 1 had neither of the 2 mutations.
CONCLUSIONS: The prevalence of clarithromycin-resistant H. pylori isolates in Taiwanese children is 18%. PCR-RFLP had a high sensitivity (92%) and specificity (100%) for the clarithromycin resistance gene mutation determination. The dominant mutation is A2144G. PCR-RFLP provides a rapid and accurate approach to detect clarithromycin-resistant strains within 24 h.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465837     DOI: 10.1097/00006454-200107000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

Review 1.  H pylori antibiotic resistance: prevalence, importance, and advances in testing.

Authors:  F Mégraud
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Antimicrobial effects of antioxidants with and without clarithromycin on Helicobacter pylori.

Authors:  Archana Chatterjee; Debasis Bagchi; Taharat Yasmin; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

3.  High prevalence of clarithromycin resistance and cagA, vacA, iceA2, and babA2 genotypes of Helicobacter pylori in Brazilian children.

Authors:  Gabriella T Garcia; Katia R S Aranda; Manoel E P Gonçalves; Silvia R Cardoso; Kiyoshi Iriya; Neusa P Silva; Isabel C A Scaletsky
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

4.  The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin compared to clarithromycin, on Helicobacter pylori.

Authors:  Archana Chatterjee; Taharat Yasmin; Debasis Bagchi; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

5.  Advances in gastric cancer prevention.

Authors:  Antonio Giordano; Letizia Cito
Journal:  World J Clin Oncol       Date:  2012-09-10

6.  Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis.

Authors:  Teresa Alarcón; Alba E Vega; Diego Domingo; Maria Josefa Martínez; Manuel López-Brea
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

7.  Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarithromycin.

Authors:  Archana Chatterjee; Taharat Yasmin; Debasis Bagchi; Sidney J Stohs
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

8.  Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication.

Authors:  Wei-Chen Tai; Chih-Ming Liang; Chen-Hsiang Lee; Chien-Hua Chiu; Ming-Luen Hu; Lung-Sheng Lu; Yuan-Hung Kuo; Chung-Mou Kuo; Yi-Hao Yen; Chung-Huang Kuo; Shue-Shian Chiou; Keng-Liang Wu; Yi-Chun Chiu; Tsung-Hui Hu; Seng-Kee Chuah
Journal:  Biomed Res Int       Date:  2015-05-19       Impact factor: 3.411

9.  Real-Time PCR detection and quantitation of Helicobacter pylori clarithromycin-resistant strains in archival material and correlation with Sydney classification.

Authors:  Sofia Gazi; Andreas Karameris; Marios Christoforou; Niki Agnantis; Theodore Rokkas; Dimitrios Stefanou
Journal:  Ann Gastroenterol       Date:  2013

10.  Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history.

Authors:  Zhuoqi Liu; Jing Shen; Lian Zhang; Lin Shen; Qiang Li; Baozhen Zhang; Jing Zhou; Liankun Gu; Guoshuang Feng; Junling Ma; Wei-Cheng You; Dajun Deng
Journal:  BMC Microbiol       Date:  2008-05-28       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.